BOM:530233 (India)
Â
Shs Dematerialised
₹
194.80
(+1.99%)
Jul 5
Business Description
Auro Laboratories Ltd
ISIN : INE292C01011
Share Class Description:
BOM:530233: Shs DematerialisedCompare
Compare
Traded in other countries / regions
530233.India IPO Date
2000-11-13Description
Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.63 | |||||
Debt-to-EBITDA | 2.46 | |||||
Interest Coverage | 18.57 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.46 | |||||
Beneish M-Score | -3.34 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.1 | |||||
3-Year EBITDA Growth Rate | 0.5 | |||||
3-Year EPS without NRI Growth Rate | 2.8 | |||||
3-Year Book Growth Rate | 13.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.1 | |||||
9-Day RSI | 44.45 | |||||
14-Day RSI | 44.15 | |||||
6-1 Month Momentum % | 39.89 | |||||
12-1 Month Momentum % | 137.72 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.29 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 173.43 | |||||
Days Sales Outstanding | 100.45 | |||||
Days Payable | 128.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -10.82 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.74 | |||||
Operating Margin % | 20.45 | |||||
Net Margin % | 16.66 | |||||
FCF Margin % | -39.59 | |||||
ROE % | 18.78 | |||||
ROA % | 10.45 | |||||
ROIC % | 12.98 | |||||
ROC (Joel Greenblatt) % | 20.49 | |||||
ROCE % | 20.01 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.13 | |||||
PE Ratio without NRI | 17.13 | |||||
Shiller PE Ratio | 27.45 | |||||
Price-to-Owner-Earnings | 18.91 | |||||
PEG Ratio | 10.71 | |||||
PS Ratio | 2.85 | |||||
PB Ratio | 2.89 | |||||
Price-to-Tangible-Book | 2.89 | |||||
Price-to-Operating-Cash-Flow | 6.46 | |||||
EV-to-EBIT | 14.87 | |||||
EV-to-EBITDA | 13.72 | |||||
EV-to-Revenue | 3.44 | |||||
EV-to-FCF | -8.69 | |||||
Price-to-Projected-FCF | 3.37 | |||||
Price-to-DCF (Earnings Based) | 0.72 | |||||
Price-to-Median-PS-Value | 3.35 | |||||
Price-to-Graham-Number | 1.41 | |||||
Earnings Yield (Greenblatt) % | 6.72 | |||||
FCF Yield % | -13.86 | |||||
Forward Rate of Return (Yacktman) % | 1.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Auro Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 425.17 | ||
EPS (TTM) (₹) | 11.37 | ||
Beta | 0.37 | ||
Volatility % | 81.03 | ||
14-Day RSI | 44.15 | ||
14-Day ATR (₹) | 7.241383 | ||
20-Day SMA (₹) | 201.535 | ||
12-1 Month Momentum % | 137.72 | ||
52-Week Range (₹) | 75.12 - 307.2 | ||
Shares Outstanding (Mil) | 6.23 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Auro Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Auro Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Auro Laboratories Ltd Frequently Asked Questions
What is Auro Laboratories Ltd(BOM:530233)'s stock price today?
The current price of BOM:530233 is ₹194.80. The 52 week high of BOM:530233 is ₹307.20 and 52 week low is ₹75.12.
When is next earnings date of Auro Laboratories Ltd(BOM:530233)?
The next earnings date of Auro Laboratories Ltd(BOM:530233) is .
Does Auro Laboratories Ltd(BOM:530233) pay dividends? If so, how much?
Auro Laboratories Ltd(BOM:530233) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |